Natco Pharma Limited has informed the Exchange regarding a press release dated March 03, 2026, titled “NATCO announces launch of Pomalidomide Capsules (generic of Pomalyst®) in the U.S. market”. |SUBJECT: Press Release
Thursday, Oct 08, 2026